Fund HoldingsGILEAD SCIENCES, INC.

Total Portfolio Value
$1.18B
Total Bought
$206.73M
Total Sold
$10.00M
Net Transaction
+$196.73M
Filing Period:
Securities
SharesValue ($K)
Q4 2024
Q1 2025
Change
Q4 2024
Q1 2025
Weight (%)
Change
KALARIS THERAPEUTICS INC0723,273+723,27305,8080.49%+5,808
MERUS N V452,527452,527019,02919,0471.61%+18
KRONOS BIO INC188,5670-188,5671790-179
BARINTHUS BIOTHERAPEUTICS PL620,351369,855-250,4967493600.03%-390
AGENUS INC231,6630-231,6636350-635
ALLOGENE THERAPEUTICS INC1,156,6891,156,68902,4641,6890.14%-775
HOOKIPA PHARMA INC1,875,9451,875,94503,7712,0260.17%-1,745
IKENA ONCOLOGY INC2,008,3381,159,145-849,1933,2941,4840.13%-1,810
XILIO THERAPEUTICS INC9,105,4519,105,45108,6966,5960.56%-2,100
ALLOVIR INC16,635,2860-16,635,2866,9870-6,987
KYVERNA THERAPEUTICS INC4,126,1194,126,119015,4327,9630.67%-7,468
TANGO THERAPEUTICS INC(TNGX)4,854,4434,854,443015,0006,6510.56%-8,350
LEAP THERAPEUTICS INC5,319,1485,319,148015,2931,6230.14%-13,670
ASSEMBLY BIOSCIENCES INC2,209,4712,209,471034,86521,1231.79%-13,743
GALAPAGOS NV(LKFT)16,707,47716,707,4770461,727419,39435.50%-42,333
ARCELLX INC
COMMON STOCK
6,720,8036,720,8030515,418440,88537.32%-74,534
ARCUS BIOSCIENCES INC(RCUS)30,061,12431,424,760+1,363,636447,610246,68420.88%-200,926
Page 1 of 1